Amylyx Pharmaceuticals (AMLX) Return on Sales [ROS] (2021 - 2025)
Amylyx Pharmaceuticals (AMLX) posted Return on Sales [ROS] of -28692.90% for Q1 2025, down 28555.12 percentage points from -137.78% a year earlier and down 28341.03 percentage points from the prior quarter.
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Return on Sales [ROS] (2021 - 2025) Analysis & Trends
For FY2024, Amylyx Pharmaceuticals' Return on Sales [ROS] came in at -360.10%, down 370.29 percentage points from FY2023.
- Annual Return on Sales [ROS] shows a three-year change of +28653.23 percentage points (FY2021 to FY2024).
- In prior years, Amylyx Pharmaceuticals' Return on Sales [ROS] was 10.19% in FY2023 (+915.91 pp), -905.72% in FY2022 (+28107.62 pp) and -29013.33% in FY2021.
- The Q1 2025 figure stands as the lowest quarterly Return on Sales [ROS] in data going back to Q3 2021.
- On a year-over-year basis, Return on Sales [ROS] has declined in each of the last five quarters, with an average year-over-year change of -5521.99 percentage points over the last seven quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q3 2023, with a gain of 15867.79 percentage points; the weakest was Q1 2025, with a drop of 28555.12 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -351.87% (Q4 2024), -18187.74% (Q3 2024) and -7457.09% (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Amylyx Pharmaceuticals | 3.09 Bn | 3.09 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -28,692.90% |
| Dec 31, 2024 | -351.87% |
| Sep 30, 2024 | -18,187.74% |
| Jun 30, 2024 | -7,457.09% |
| Mar 31, 2024 | -137.78% |
| Dec 31, 2023 | 1.78% |
| Sep 30, 2023 | 18.23% |
| Jun 30, 2023 | 20.57% |
| Mar 31, 2023 | -2.87% |
| Dec 31, 2022 | -203.76% |
| Sep 30, 2022 | -15,849.57% |
| Sep 30, 2021 | -8,041.40% |
API Access
Amylyx Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AMLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "AMLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AMLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();